✦ LIBER ✦

An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

✍ Scribed by Chandiwana, D.; Vieira, J.; Granville, J.; McCool, R.; Fleetwood, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison Between Everolimus (Afinitor®

✍ Vieira, J.; Chandiwana, D.; Taylor, M.; Lewis, L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN98 Health Outcome Gains and Costs Off

✍ M. Taylor; L. Lewis; J. Vieira; J.F. Ricci; D. Chandiwana; S. Saletan; T. Sahmou 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

NICE guidance on everolimus in combinati

✍ Burke, Martyn J; Garrett, Zoe; George, Elisabeth; Adler, Amanda I 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 53 KB

Systematic review of lapatinib in combin

✍ Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Dia 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 385 KB

PCN15 SYSTEMATIC REVIEW OF LAPATINIB PLU

✍ R Riemsma; CA Forbes; M Amonkar; K Lykopoulos; JR Diaz; J Kleijnen; DW Rea 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Everolimus in Combination with Exemestan

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB